Last update:

Six-week postpartum monitoring uncovers 40% more severe pregnancy complications

Extending the monitoring period for severe pregnancy complications showed that more than 40% of cases were missed using traditional delivery-focused monitoring, according to new research that extended monitoring from conception ...

Brain scans reveal link between thinner brain cortex regions and higher psychopathic traits

A team of researchers from Spain was curious to know if people with high psychopathic traits have anomalies in the brain's physical structures, which make them incapable of feeling regret or capable of manipulation and other ...

Medical research news

Q&A: Gassing up bioengineered materials for wound healing

Biomaterials are specifically engineered to support tissue, nerve and muscle regeneration across the body, yet physicians and researchers have limited control over the size and connectivity of the internal pores that transfer ...

How vitamin B2 could pave the way to new cancer therapies

The human body cannot produce vitamin B2—also known as riboflavin—itself; it must absorb the important substance through diet. The vitamin can be found in dairy products, eggs, meat and green vegetables. The metabolism ...

Specific gut bacteria species linked to muscle strength

A species of gut bacteria called Roseburia inulinivorans is specifically associated with human muscle strength and improved muscular performance in mice, finds research published online in the journal Gut.

Cannabis intoxication disrupts many types of memory

Smoking cannabis can do more than blur memories. It can reshape them. A new Washington State University study found that people who consumed THC were more likely to recall words that were never presented and struggled with ...

Boron agents reach previously untreatable tumors

Boron agents termed GluBs, developed by Science Tokyo researchers, have overcome a key limitation in cancer therapy by entering tumor cells through a pathway that standard drugs cannot use. The GluBs target ASCT2, a transporter ...

New mRNA platform remains effective even in aging and obesity

Since the COVID-19 pandemic, mRNA vaccines have gained attention as a next-generation pharmaceutical technology. mRNA therapeutics work by delivering genetic instructions that enable cells to produce specific proteins for ...

How one receptor can help—or hurt—your blood vessels

Researchers at the University of California San Diego have uncovered how a single protein triggers two opposite responses in blood vessels—one inflammatory and one protective. This protein, a cell-surface receptor called ...

Approved IV drug reduces lupus symptoms, clinical trial finds

An already-approved IV drug significantly reduces the symptoms of lupus, a new clinical trial showed. More than three-quarters of lupus patients taking obinutuzumab (Gazvya) had a significant improvement in their symptoms ...